Ownership Summary
The institutional landscape for Addex Therapeutics Ltd. (NASDAQ:ADXN) includes 4 filers as of the latest reporting cycle ending September 2025.
- These investors collectively held 0.0% of the company's total shares outstanding in September 2025, down from 0.0% in June 2025.
- The company experienced a 0.51% quarterly change in institutional shares held, alongside an increase of 33.33% in total owners annually.
- The latest 13F cycle for Addex Therapeutics reveals that of 4 total investors, 1 funds grew their exposure, whereas 0 reduced theirs and 3 made no changes.
- The aggregate institutional position in Addex Therapeutics now stands at 199 shares as of September 2025, after investors increased their holdings (up by 1 shares quarter on quarter which is down 1.19K shares year over year).
- GAMMA Investing LLC's holding of 121 shares as of September 30, 2025 makes it the primary institutional investor in Addex Therapeutics, owning 0.00% of the stock.
- Among the most significant buyers of Addex Therapeutics during September 2025 were UBS Group AG (1).
- The top 4 institutional holders of Addex Therapeutics for the quarter ending September 2025 included GAMMA Investing LLC (121), RHUMBLINE ADVISERS (72), SBI Securities Co., Ltd. (5), UBS Group AG (1).